Status:

COMPLETED

VH-IVUS Plaque Composition Analysis By Fractional Flow Reserve

Lead Sponsor:

Inje University

Collaborating Sponsors:

Seoul National University Hospital

Conditions:

Coronary Disease

Eligibility:

All Genders

20-85 years

Brief Summary

Recent clinical trials demonstrated that virtual histology-intravascular ultrasound (VH-IVUS) is a useful test predicting clinical outcomes of the coronary artery disease (CAD). Thin cap fibroatheroma...

Eligibility Criteria

Inclusion

  • clinical angina pectoris who underwent VH-IVUS and FFR during coronary angiography.
  • agree with informed consent

Exclusion

  • unable to get informed consent
  • low left ventricular ejection fraction less than 35%
  • chronic renal failure (Cr\>2.0mg/dl)
  • acute myocardial infarction related coronary artery
  • allergy to adenosine injection

Key Trial Info

Start Date :

March 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01444599

Start Date

March 1 2010

End Date

December 1 2014

Last Update

March 24 2015

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Inje University Ilsan Paik Hospital

Goyang, Gyeonggido, South Korea, 411-709

2

Seoul National University Hospital

Seoul, Seoul, South Korea

3

Keimyung University Dongsan Medical Center

Daegu, South Korea

4

Ulsan University Hospital

Ulsan, South Korea

VH-IVUS Plaque Composition Analysis By Fractional Flow Reserve | DecenTrialz